Ad is loading...
AZTA
Price
$45.16
Change
-$0.37 (-0.81%)
Updated
Nov 22 closing price
79 days until earnings call
BLFS
Price
$26.01
Change
+$0.62 (+2.44%)
Updated
Nov 22 closing price
109 days until earnings call
Ad is loading...

AZTA vs BLFS

Header iconAZTA vs BLFS Comparison
Open Charts AZTA vs BLFSBanner chart's image
Azenta
Price$45.16
Change-$0.37 (-0.81%)
Volume$10.02M
CapitalizationN/A
BioLife Solutions
Price$26.01
Change+$0.62 (+2.44%)
Volume$585.68K
CapitalizationN/A
AZTA vs BLFS Comparison Chart
Loading...
AZTA
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
BLFS
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
AZTA vs. BLFS commentary
Nov 24, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AZTA is a StrongBuy and BLFS is a Buy.

COMPARISON
Comparison
Nov 24, 2024
Stock price -- (AZTA: $45.16 vs. BLFS: $26.01)
Brand notoriety: AZTA and BLFS are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: AZTA: 1292% vs. BLFS: 145%
Market capitalization -- AZTA: $3.36B vs. BLFS: $810.87M
AZTA [@Medical Specialties] is valued at $3.36B. BLFS’s [@Medical Specialties] market capitalization is $810.87M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $7.99B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AZTA’s FA Score shows that 0 FA rating(s) are green whileBLFS’s FA Score has 1 green FA rating(s).

  • AZTA’s FA Score: 0 green, 5 red.
  • BLFS’s FA Score: 1 green, 4 red.
According to our system of comparison, BLFS is a better buy in the long-term than AZTA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AZTA’s TA Score shows that 5 TA indicator(s) are bullish while BLFS’s TA Score has 6 bullish TA indicator(s).

  • AZTA’s TA Score: 5 bullish, 4 bearish.
  • BLFS’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, BLFS is a better buy in the short-term than AZTA.

Price Growth

AZTA (@Medical Specialties) experienced а +8.79% price change this week, while BLFS (@Medical Specialties) price change was +23.74% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +3.02%. For the same industry, the average monthly price growth was +0.79%, and the average quarterly price growth was -2.06%.

Reported Earning Dates

AZTA is expected to report earnings on Feb 11, 2025.

BLFS is expected to report earnings on Mar 13, 2025.

Industries' Descriptions

@Medical Specialties (+3.02% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AZTA($3.36B) has a higher market cap than BLFS($811M). BLFS YTD gains are higher at: 60.062 vs. AZTA (-30.672). AZTA has higher annual earnings (EBITDA): 57.5M vs. BLFS (-45.24M). AZTA has more cash in the bank: 984M vs. BLFS (51.7M). BLFS has less debt than AZTA: BLFS (42.7M) vs AZTA (66.5M). AZTA has higher revenues than BLFS: AZTA (641M) vs BLFS (143M).
AZTABLFSAZTA / BLFS
Capitalization3.36B811M415%
EBITDA57.5M-45.24M-127%
Gain YTD-30.67260.062-51%
P/E RatioN/A238.10-
Revenue641M143M448%
Total Cash984M51.7M1,903%
Total Debt66.5M42.7M156%
FUNDAMENTALS RATINGS
AZTA vs BLFS: Fundamental Ratings
AZTA
BLFS
OUTLOOK RATING
1..100
370
VALUATION
overvalued / fair valued / undervalued
1..100
69
Overvalued
95
Overvalued
PROFIT vs RISK RATING
1..100
9379
SMR RATING
1..100
9193
PRICE GROWTH RATING
1..100
5940
P/E GROWTH RATING
1..100
7022
SEASONALITY SCORE
1..100
85n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

AZTA's Valuation (69) in the Electronic Production Equipment industry is in the same range as BLFS (95) in the Medical Specialties industry. This means that AZTA’s stock grew similarly to BLFS’s over the last 12 months.

BLFS's Profit vs Risk Rating (79) in the Medical Specialties industry is in the same range as AZTA (93) in the Electronic Production Equipment industry. This means that BLFS’s stock grew similarly to AZTA’s over the last 12 months.

AZTA's SMR Rating (91) in the Electronic Production Equipment industry is in the same range as BLFS (93) in the Medical Specialties industry. This means that AZTA’s stock grew similarly to BLFS’s over the last 12 months.

BLFS's Price Growth Rating (40) in the Medical Specialties industry is in the same range as AZTA (59) in the Electronic Production Equipment industry. This means that BLFS’s stock grew similarly to AZTA’s over the last 12 months.

BLFS's P/E Growth Rating (22) in the Medical Specialties industry is somewhat better than the same rating for AZTA (70) in the Electronic Production Equipment industry. This means that BLFS’s stock grew somewhat faster than AZTA’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AZTABLFS
RSI
ODDS (%)
Bullish Trend 3 days ago
72%
Bullish Trend 3 days ago
83%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
72%
Bullish Trend 3 days ago
85%
Momentum
ODDS (%)
Bullish Trend 3 days ago
77%
Bearish Trend 3 days ago
84%
MACD
ODDS (%)
Bullish Trend 3 days ago
73%
Bullish Trend 3 days ago
77%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
71%
Bullish Trend 3 days ago
81%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
76%
Bullish Trend 3 days ago
82%
Advances
ODDS (%)
Bullish Trend 4 days ago
72%
Bullish Trend 3 days ago
79%
Declines
ODDS (%)
Bearish Trend 7 days ago
84%
Bearish Trend 7 days ago
84%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
73%
Bullish Trend 3 days ago
83%
Aroon
ODDS (%)
Bearish Trend 3 days ago
81%
Bearish Trend 3 days ago
83%
View a ticker or compare two or three
Ad is loading...
AZTA
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
BLFS
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
OSGCX10.910.17
+1.58%
JPMorgan Small Cap Growth C
NCTWX37.050.52
+1.42%
Nicholas II I
NDGIX22.380.15
+0.67%
Neuberger Berman Dividend Growth I
RREAX29.800.17
+0.57%
Russell Inv Global Real Estate Secs A
RNPAX60.190.25
+0.42%
American Funds New Perspective R1

AZTA and

Correlation & Price change

A.I.dvisor indicates that over the last year, AZTA has been loosely correlated with CRL. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if AZTA jumps, then CRL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AZTA
1D Price
Change %
AZTA100%
-0.81%
CRL - AZTA
58%
Loosely correlated
+0.81%
BLFS - AZTA
53%
Loosely correlated
+2.44%
RVTY - AZTA
53%
Loosely correlated
+0.83%
IQV - AZTA
52%
Loosely correlated
+2.14%
RGEN - AZTA
50%
Loosely correlated
+0.58%
More

BLFS and

Correlation & Price change

A.I.dvisor indicates that over the last year, BLFS has been loosely correlated with AZTA. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if BLFS jumps, then AZTA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BLFS
1D Price
Change %
BLFS100%
+2.44%
AZTA - BLFS
53%
Loosely correlated
-0.81%
VCYT - BLFS
50%
Loosely correlated
+1.67%
RGEN - BLFS
48%
Loosely correlated
+0.58%
MASS - BLFS
47%
Loosely correlated
-6.57%
RVTY - BLFS
45%
Loosely correlated
+0.83%
More